The FDA is directing GLP-1 drugmakers to add warnings about a rare optic nerve condition, while saying its review does not prove the drugs cause it.
FDA Orders New Warning Labels On Ozempic, Wegovy Over Rare Risk Of Permanent Vision Loss
